2. "On the face of it the HVAD is the best thing since sliced bread so why hasn't it taken off? Why did Appletree dump stock so close to the end? There are a lot of unanswered questions here."
It hasnt taken off yet because they are still waiting on FDA approval for the US which l beleive is expected early 2012. The US market is by far the largest. Sales in Europe are progressing well and as with any product ramping up sales takes time. Appletree if l'm correct are venture capital specialists and their selling is not dumping but rather taking substantial profits.
3. The buying opportunity you're looking for is probably staring you in the face right now. FDA approval will rerate this stock to the tune of 100% minimum.
l'm very comfortable holding HIN and it surprises me the lack of interest on the ASX.
HIN Price at posting:
$1.72 Sentiment: Buy Disclosure: Held